Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Regulation
4 Regulatory Developments to Follow in 2023
Federal government regulators are taking aggressive stances to protect workers, ensure fair markets, and keep investors informed.
By
Vincent Ryan
| January 31, 2023
Read More
Resources
CFO Live
2022 Survey
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
2022 Survey
Sign Up
Sponsored by
NBGH
Risk & Compliance
House to Vote for Repeal of ACA’s ‘Cadillac Tax’
Despite strong bipartisan support for a repeal of the onerous excise tax on health benefits, its fate in the Senate remains unclear.
By
David McCann
| July 17, 2019
Read More
Risk & Compliance
How to Rein In the Soaring Costs of Specialty Drugs
The 420-employer National Business Group on Health recommends public-policy changes relating to the proliferating category of specialty drugs.
By
David McCann
| January 30, 2017
Read More
Human Capital & Careers
Specialty Drugs Drive Health Care Cost Trend
Health benefits costs are forecast to climb 5% next year, thanks in part to fast-rising prices for specialty pharmaceuticals.
By
David McCann
| August 9, 2016
Read More
Tax
Two-Year Delay for Obamacare’s Cadillac Tax Likely
A proposal to postpone the despised excise tax is an 11th-hour inclusion in the federal budget bill.
By
David McCann
| December 16, 2015
Read More
Human Capital & Careers
Rallying Against the Cadillac Tax
Companies, unions, and politicians on both sides of the aisle seek to repeal the coming excise tax on high-cost health plans.
By
David McCann
| December 15, 2015
Read More
Human Capital & Careers
Health-Care Cost Hikes Stay Modest for Big Companies
The average company with more than 1,000 employees will pay 4.4 percent more in 2014 than it did last year, new research says.
By
David McCann
| March 7, 2014
Read More